Dr Clyde Yancy: We Must Continue to Explore Why SGLT2 Inhibitors Are Effective in HF

July 27, 2021 12:00pm

We do not yet know the exact mechanism of action of sodium glucose co-transporter-2 (SGLT2) inhibitors in heart failure (HF), but there are many exciting pssibilities, stated Clyde W. Yancy, MD, MSc, of Northwestern University’s Feinberg School of Medicine.

Assessing the Relationship Between Obesity and Pediatric-Onset MS
Alliance for Patient Access Releases Paper on Biosimilar Best Practices in Oncology
UK Biobank Study Reveals IBS, Peptic Ulcers Linked With Migraine
Medical Groups Call for Mandatory COVID-19 Vaccinations for Health Care Staff